PHARMACOLOGY AND THERAPEUTIC CONSIDERATIONS OF AMLODIPINE, A NEW 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONIST - GENERAL DISCUSSION

被引：0
|
作者：
VANZWIETEN, PA
LUCCHESI, BR
CATAPANO, AL
VANHOUTTE
VANBREEMEN
MILLARD, RW
VANHOUTTE
GODFRAIND, T
EPSTEIN, M
BLACKBURN
SCHWARTZ, A
NAYLER, WG
BURGES, RA
MARSHALL
机构：
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CARDIOL, 1105 AZ AMSTERDAM, NETHERLANDS
[2] UNIV MICHIGAN, SCH MED, DEPT PHARMACOL, ANN ARBOR, MI 48109 USA
[3] UNIV MILAN, INST PHARMACOL SCI, I-20133 MILAN, ITALY
[4] UNIV CINCINNATI, COLL MED, DEPT PHARMACOL & CELL BIOPHYS, CINCINNATI, OH 45267 USA
[5] CATHOLIC UNIV LOUVAIN, PHARMACODYNAM GEN & PHARMACOL LAB, B-1200 BRUSSELS, BELGIUM
[6] VET ADM MED CTR, NEPHROL SECT, MIAMI, FL 33125 USA
[7] UNIV CINCINNATI, COLL MED, DEPT RADIOL, CINCINNATI, OH 45267 USA
[8] UNIV MELBOURNE, AUSTIN HOSP, DEPT MED, HEIDELBERG, VIC 3084, AUSTRALIA
[9] PFIZER LTD, DEPT DISCOVERY BIOL, SANDWICH CT13 9NJ, KENT, ENGLAND
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1989年 / 64卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I135 / I137
页数：3
相关论文
共 50 条
  • [31] Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: Comparison with nifedipine and amlodipine
    Hirano, T
    Ohura, M
    Orito, K
    Fujiki, H
    Miyakoda, G
    Mori, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 324 (2-3) : 201 - 204
  • [32] PHARMACODYNAMICS OF NILVADIPINE, A NEW DIHYDROPYRIDINE-TYPE CALCIUM-ANTAGONIST
    HONERJAGER, P
    SEIBEL, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S15 - S21
  • [33] Obtaining antibodies to 1,4-Dihydropyridine calcium channel antagonists
    A. A. Burkin
    M. A. Burkin
    Applied Biochemistry and Microbiology, 2008, 44 : 323 - 327
  • [34] QSAR STUDY ON 1,4-DIHYDROPYRIDINE AS CALCIUM CHANNEL ANTAGONISTS
    Singh, J.
    Shaik, B.
    Shukla, S. K.
    Sharma, M.
    Singh, S.
    Agrawal, V. K.
    OXIDATION COMMUNICATIONS, 2013, 36 (03): : 761 - 777
  • [35] Obtaining antibodies to 1,4-dihydropyridine calcium channel antagonists
    Burkin, A. A.
    Burkin, M. A.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2008, 44 (03) : 323 - 327
  • [36] QSAR Analysis of 1,4-Dihydropyridine Calcium Channel Antogonists
    Kahraman, Pinar
    Turkay, Metin
    17TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2007, 24 : 977 - 982
  • [37] VOLTAMMETRIC BEHAVIOR OF 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONISTS
    ALVAREZLUEJE, A
    NUNEZVERGARA, LJ
    SQUELLA, JA
    ELECTROANALYSIS, 1994, 6 (03) : 259 - 264
  • [38] 1,4-DIHYDROPYRIDINE ANTAGONIST ACTIVITIES AT THE CALCIUM-CHANNEL - A QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP APPROACH
    COBURN, RA
    WIERZBA, M
    SUTO, MJ
    SOLO, AJ
    TRIGGLE, AM
    TRIGGLE, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (11) : 2103 - 2107
  • [39] ARTERIAL VASODILATOR EFFECTS OF THE DIHYDROPYRIDINE CALCIUM-ANTAGONIST AMLODIPINE ALONE AND IN COMBINATION WITH VERAPAMIL IN SYSTEMIC HYPERTENSION
    KIOWSKI, W
    ERNE, P
    LINDER, L
    BUHLER, FR
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (20): : 1469 - 1472
  • [40] DIFFERENTIAL-EFFECTS OF 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS - THERAPEUTIC IMPLICATIONS
    KATZ, AM
    LEACH, NM
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (11): : 825 - 834
12345